MedTrace Logo

Electroencephalographic Biofeedback Therapy in Heroin Craving

NCT06840912 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2025-02-21

No results posted yet for this study

Summary

The aim of this work is to assess the effectiveness of electroencephalography (EEG) biofeedback in management of heroin craving .

Conditions

  • Electroencephalographic
  • Biofeedback Therapy
  • Heroin
  • Craving

Interventions

OTHER

Pharmacological in addition to electroencephalographic (EEG) biofeedback

Patients with heroin use disorder diagnosed according to DSM-5 criteria (Diagnostic and Statistical Manual of Mental Disorders 5th edition), treated by pharmacological in addition to electroencephalography (EEG) biofeedback after 3 months of abstinence.

DRUG

Pharmacotherapy

Patients with heroin use disorder taken as control group matching with patients group treated only by pharmacotherapy

Sponsors & Collaborators

  • Tanta University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
50 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-02-01
Primary Completion
2024-05-01
Completion
2024-05-01

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06840912 on ClinicalTrials.gov